IN192527B - - Google Patents
Info
- Publication number
- IN192527B IN192527B IN983DE2001A IN192527B IN 192527 B IN192527 B IN 192527B IN 983DE2001 A IN983DE2001 A IN 983DE2001A IN 192527 B IN192527 B IN 192527B
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN983DE2001 IN192527B (de) | 2001-09-25 | 2001-09-25 | |
| ES02775017T ES2242068T3 (es) | 2001-09-25 | 2002-09-24 | Proceso de preparacion de repaglinida. |
| US10/490,275 US7148355B2 (en) | 2001-09-25 | 2002-09-24 | Process for the preparation of repaglinide |
| AT02775017T ATE296287T1 (de) | 2001-09-25 | 2002-09-24 | Verfahren zur herstellung von repaglinide |
| CA002461087A CA2461087A1 (en) | 2001-09-25 | 2002-09-24 | Process for the preparation of repaglinide |
| DE60204334T DE60204334T2 (de) | 2001-09-25 | 2002-09-24 | Verfahren zur Herstellung von Repaglinid |
| PT02775017T PT1432682E (pt) | 2001-09-25 | 2002-09-24 | Processo para a preparacao de repaglinida |
| BR0212772-5A BR0212772A (pt) | 2001-09-25 | 2002-09-24 | Processo para a preparação de repaglinida |
| EP02775017A EP1432682B1 (de) | 2001-09-25 | 2002-09-24 | Verfahren zur herstellung von repaglinide |
| PCT/IB2002/003943 WO2003027072A1 (en) | 2001-09-25 | 2002-09-24 | Process for the preparation of repaglinide |
| CNA028204492A CN1571769A (zh) | 2001-09-25 | 2002-09-24 | 瑞格列奈的制备方法 |
| JP2003530663A JP2005521634A (ja) | 2001-09-25 | 2002-09-24 | レパグリニドの製法 |
| ARP020103594A AR036623A1 (es) | 2001-09-25 | 2002-09-25 | Proceso para la preparacion de repaglinida |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN983DE2001 IN192527B (de) | 2001-09-25 | 2001-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN192527B true IN192527B (de) | 2004-04-24 |
Family
ID=11097115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN983DE2001 IN192527B (de) | 2001-09-25 | 2001-09-25 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7148355B2 (de) |
| EP (1) | EP1432682B1 (de) |
| JP (1) | JP2005521634A (de) |
| CN (1) | CN1571769A (de) |
| AR (1) | AR036623A1 (de) |
| AT (1) | ATE296287T1 (de) |
| BR (1) | BR0212772A (de) |
| CA (1) | CA2461087A1 (de) |
| DE (1) | DE60204334T2 (de) |
| ES (1) | ES2242068T3 (de) |
| IN (1) | IN192527B (de) |
| PT (1) | PT1432682E (de) |
| WO (1) | WO2003027072A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040102477A1 (en) * | 2002-08-23 | 2004-05-27 | Dr. Reddy's Laboratories Limited | Polymorphic forms of (S)-Repaglinide and the processes for preparation thereof |
| EP1636199A2 (de) * | 2003-05-14 | 2006-03-22 | Cilag AG | Verfahren zur herstellung von phenylessig derivaten |
| WO2004103983A1 (en) * | 2003-05-26 | 2004-12-02 | Biocon Limited | Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives |
| CN100445275C (zh) * | 2006-06-21 | 2008-12-24 | 浙江大学 | 一种合成瑞格列奈的工艺 |
| US8101769B2 (en) * | 2007-02-15 | 2012-01-24 | Actavis Group Ptc Ehf | Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide |
| EP2155706A2 (de) * | 2007-06-06 | 2010-02-24 | Actavis Group PTC EHF | Substantiell von dimer-unreinheit freies repaglinid |
| CN101481363B (zh) * | 2008-01-10 | 2011-05-04 | 江苏豪森药业股份有限公司 | 一种制备瑞格列奈的方法 |
| CN101220007B (zh) * | 2008-01-16 | 2010-09-15 | 浙江耐司康药业有限公司 | 一种制备瑞格列奈的方法 |
| CN102267959B (zh) * | 2011-07-06 | 2013-05-01 | 海南锦瑞制药股份有限公司 | 一种瑞格列奈晶体、其制备方法及含有该晶体的固体口服制剂 |
| CN103012319B (zh) * | 2011-09-20 | 2015-06-10 | 浙江九洲药业股份有限公司 | 瑞格列奈中间体的合成工艺改进 |
| CN102633750A (zh) * | 2012-03-26 | 2012-08-15 | 浙江昂利康制药有限公司 | 一锅法合成治疗糖尿病的药物瑞格列奈 |
| CN102731436A (zh) * | 2012-04-09 | 2012-10-17 | 海南中化联合制药工业股份有限公司 | 一种瑞格列奈的制备及精制方法 |
| CN104557778A (zh) * | 2015-01-09 | 2015-04-29 | 蔡伦 | 一种瑞格列奈的制备方法及其应用 |
| CN105198838A (zh) * | 2015-10-21 | 2015-12-30 | 河南普瑞制药有限公司 | 一种瑞格列奈的制备方法 |
| CN105906583B (zh) * | 2015-12-23 | 2018-03-09 | 嘉实（湖南）医药科技有限公司 | 一种瑞格列奈中间体的制备工艺 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5965094A (ja) * | 1982-10-06 | 1984-04-13 | Sumitomo Chem Co Ltd | セフアロスポリン化合物の製造法 |
| US5312924A (en) * | 1983-12-30 | 1994-05-17 | Dr. Karl Thomae Gmbh | Phenylacetic acid benzylamides |
-
2001
- 2001-09-25 IN IN983DE2001 patent/IN192527B/en unknown
-
2002
- 2002-09-24 CA CA002461087A patent/CA2461087A1/en not_active Abandoned
- 2002-09-24 BR BR0212772-5A patent/BR0212772A/pt not_active Application Discontinuation
- 2002-09-24 DE DE60204334T patent/DE60204334T2/de not_active Expired - Fee Related
- 2002-09-24 EP EP02775017A patent/EP1432682B1/de not_active Expired - Lifetime
- 2002-09-24 JP JP2003530663A patent/JP2005521634A/ja active Pending
- 2002-09-24 ES ES02775017T patent/ES2242068T3/es not_active Expired - Lifetime
- 2002-09-24 PT PT02775017T patent/PT1432682E/pt unknown
- 2002-09-24 US US10/490,275 patent/US7148355B2/en not_active Expired - Fee Related
- 2002-09-24 WO PCT/IB2002/003943 patent/WO2003027072A1/en active IP Right Grant
- 2002-09-24 CN CNA028204492A patent/CN1571769A/zh active Pending
- 2002-09-24 AT AT02775017T patent/ATE296287T1/de not_active IP Right Cessation
- 2002-09-25 AR ARP020103594A patent/AR036623A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2461087A1 (en) | 2003-04-03 |
| PT1432682E (pt) | 2005-09-30 |
| WO2003027072A1 (en) | 2003-04-03 |
| EP1432682B1 (de) | 2005-05-25 |
| JP2005521634A (ja) | 2005-07-21 |
| DE60204334T2 (de) | 2006-03-23 |
| ATE296287T1 (de) | 2005-06-15 |
| BR0212772A (pt) | 2004-10-13 |
| US20050107614A1 (en) | 2005-05-19 |
| DE60204334D1 (de) | 2005-06-30 |
| EP1432682A1 (de) | 2004-06-30 |
| CN1571769A (zh) | 2005-01-26 |
| AR036623A1 (es) | 2004-09-22 |
| ES2242068T3 (es) | 2005-11-01 |
| US7148355B2 (en) | 2006-12-12 |